Advancing Microbiome Therapeutics: The Role of Co-cultured Therapies in Ulcerative Colitis & Beyond
Time: 11:30 am
day: Conference Day Two, Track One, AM
Details:
- Evaluating the promise of co-cultured microbiome therapies.
- Emergent function of diverse consortia
- Exploring a case study of the development of a co-cultured therapy for ulcerative colitis
- Highlighting regulatory and manufacturing challenges and solutions
